Bexsero logo
UK flag This site is intended for UK health professionals only

A dangerous killer Meningococcal disease can lead to death within 24-48 hours of the first symptoms, leaving a very narrow window for diagnosis and intervention

Life-long impact Among survivors of meningococcal disease,
10%-20% will be left with permanent disabilities

Introducing Bexsero® Bexsero is an innovative vaccine designed to provide broad protection against meningitis B for individuals from 2 months of age and older

Links
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard/
Adverse events should also be reported to Novartis Vaccines and Diagnostics Limited at https://psi.novartis.com/